SCHEMBL3540453

SCHEMBL3540453

Cc1cnn(-c2ccc(C(N)=O)c(N3CCCCC3)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.53
CDC7 O00311 2/20 0.48
CDK9 P50750 1/20 0.48
NPC1 O15118 1/20 0.47
ROCK2 O75116 1/20 0.45
MAP4K4 O95819 1/20 0.45
CDK2 P24941 1/20 0.45
GSK3B P49841 1/20 0.45
CLK4 Q9HAZ1 1/20 0.45
IRAK4 Q9NWZ3 1/20 0.45
HTT P42858 1/20 0.44
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
THRB P10828 1/20 0.42
ALOX15 P16050 1/20 0.42
GFER P55789 1/20 0.42
YWHAG P61981 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3539837 0.81 ALDH1A1 (0.59) CSF1RHTTKDM4EMEN1MAPT
SCHEMBL3538450 0.79 NPC1 (0.63) CDC7CDK9NPC1ROCK2MAP4K4
SCHEMBL5104519 0.78 CDC7 (0.53) CDC7CDK9NPC1ROCK2MAP4K4
SCHEMBL3346206 0.77 KAT6A (0.46) CSF1RNPC1MAP4K4HTTKDM4E
SCHEMBL3545162 0.76 MAPT (0.61) CSF1RMEN1MAPTKMT2AALDH1A1
SCHEMBL3534452 0.75 ALDH1A1 (0.56) CSF1RCDC7CDK9NPC1ROCK2
Hydrochloric Acid SCHEMBL3539657 0.74 ALDH1A1 (0.55) CSF1RCDC7CDK9NPC1ROCK2
SCHEMBL5336011 0.73 MAPT (0.54) CSF1RHTTMEN1MAPTALOX15
SCHEMBL3533599 0.73 NPC1 (0.55) CDC7CDK9NPC1ROCK2MAP4K4
SCHEMBL3536839 0.72 MAPT (0.56) CDC7CDK9NPC1ROCK2MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP claimed
EP-1807407-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP claimed
US-20060100201-A1 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-11 US claimed
WO-2006047504-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-04 WO claimed
US-7705042-B2 Class of arylamide compounds useful as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2010-04-27 US disclosed
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP disclosed
EP-1807407-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP disclosed
US-20060100201-A1 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-11 US disclosed
WO-2006047504-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100201-A1 Inhibitors of c-fms kinase MUSK, FLT3, FES CSF1R 34/4885CDC7 580/4885CDK9 396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.